Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is It Time To Reassess Sartorius (XTRA:SRT3) After Extended Share Price Weakness?
Ensuring reliable PFAS analysis
Sartorius (XTRA:SRT3) Valuation Check As Recent Weakness Contrasts With Rich P/E And DCF Upside
Kepler Capital Keeps Their Hold Rating on Sartorius (0NIR) | Markets Insider
Sartorius launches next-generation platform to boost efficiency in cell therapy production
RBC Capital Sticks to Their Hold Rating for Sartorius (0NIR) | Markets Insider
Analyzing Sonova (OTCMKTS:SONVY) & Sartorius (OTCMKTS:SARTF) - Markets Daily
Kepler Capital Sticks to Its Hold Rating for Sartorius (0NIR) | Markets Insider
Assessing Sartorius (XTRA:SRT3) Valuation As Viral Vaccine Media Demand Gains Attention
Sartorius (XTRA:SRT3) Valuation Check After 2025 Earnings Show Higher Sales And Net Income
Is Sartorius (XTRA:SRT3) Now Pricing In A Recovery After Recent Sector Sentiment Shifts
Sartorius news
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
